Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Conference/Events
American Society of Clinical Oncology (ASCO) to hold a symposium » 09:34
01/20/22
01/20
09:34
01/20/22
09:34
AGEN

Agenus

$2.82 /

-0.035 (-1.23%)

, AZN

AstraZeneca

$59.46 /

-0.37 (-0.62%)

, BAYRY

Bayer

$14.82 /

+0.13 (+0.88%)

, BMY

Bristol-Myers

$64.73 /

-0.175 (-0.27%)

, CRDF

Cardiff Oncology

$4.54 /

-1.585 (-25.88%)

, DSNKY

Daiichi Sankyo

$22.44 /

-0.5385 (-2.34%)

, DCPH

Deciphera

$8.50 /

+0.225 (+2.72%)

, DNA

Ginkgo Bioworks

$5.04 /

-0.25 (-4.73%)

, ESALY

Eisai

$52.17 /

-0.39 (-0.74%)

, EXAS

Exact Sciences

$76.09 /

-1.24 (-1.60%)

, EXEL

Exelixis

$17.09 /

-0.28 (-1.61%)

, GH

Guardant Health

$71.99 /

-0.48 (-0.66%)

, HCM

Hutchmed

$29.71 /

-0.76 (-2.49%)

, IMMVF

Immunovia

$7.40 /

+ (+0.00%)

, INCY

Incyte

$74.81 /

-0.19 (-0.25%)

, IPSEY

Ipsen

$24.15 /

+0.4145 (+1.75%)

, LLY

Eli Lilly

$245.08 /

-2.075 (-0.84%)

, MRK

Merck

$81.30 /

-0.25 (-0.31%)

, MRTX

Mirati Therapeutics

$120.93 /

+4.85 (+4.18%)

, NTRA

Natera

$61.27 /

+0.14 (+0.23%)

, NVCR

Novocure

$64.11 /

-0.37 (-0.57%)

, NVS

Novartis

$88.85 /

-0.7 (-0.78%)

, ORIC

Oric Pharmaceuticals

$11.72 /

-0.13 (-1.10%)

, PBLA

Panbela Therapeutics

$1.68 /

-0.06 (-3.45%)

, PFE

Pfizer

$53.54 /

-0.58 (-1.07%)

, SGEN

Seagen

$132.55 /

+2.2 (+1.69%)

, TPTX

Turning Point Therapeutics

$36.57 /

+0.44 (+1.22%)

, VCYT

Veracyte

$27.23 /

-0.54 (-1.94%)

, ZYME

Zymeworks

$13.44 /

+0.055 (+0.41%)

ASCO Gastrointestinal…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ZYME Zymeworks
$13.44 /

+0.055 (+0.41%)

VCYT Veracyte
$27.23 /

-0.54 (-1.94%)

TPTX Turning Point Therapeutics
$36.57 /

+0.44 (+1.22%)

SGEN Seagen
$132.55 /

+2.2 (+1.69%)

PFE Pfizer
$53.54 /

-0.58 (-1.07%)

PBLA Panbela Therapeutics
$1.68 /

-0.06 (-3.45%)

ORIC Oric Pharmaceuticals
$11.72 /

-0.13 (-1.10%)

NVS Novartis
$88.85 /

-0.7 (-0.78%)

NVCR Novocure
$64.11 /

-0.37 (-0.57%)

NTRA Natera
$61.27 /

+0.14 (+0.23%)

MRTX Mirati Therapeutics
$120.93 /

+4.85 (+4.18%)

MRK Merck
$81.30 /

-0.25 (-0.31%)

LLY Eli Lilly
$245.08 /

-2.075 (-0.84%)

IPSEY Ipsen
$24.15 /

+0.4145 (+1.75%)

INCY Incyte
$74.81 /

-0.19 (-0.25%)

HCM Hutchmed
$29.71 /

-0.76 (-2.49%)

GH Guardant Health
$71.99 /

-0.48 (-0.66%)

EXEL Exelixis
$17.09 /

-0.28 (-1.61%)

EXAS Exact Sciences
$76.09 /

-1.24 (-1.60%)

ESALY Eisai
$52.17 /

-0.39 (-0.74%)

DSNKY Daiichi Sankyo
$22.44 /

-0.5385 (-2.34%)

DNA Ginkgo Bioworks
$5.04 /

-0.25 (-4.73%)

DCPH Deciphera
$8.50 /

+0.225 (+2.72%)

CRDF Cardiff Oncology
$4.54 /

-1.585 (-25.88%)

BMY Bristol-Myers
$64.73 /

-0.175 (-0.27%)

BAYRY Bayer
$14.82 /

+0.13 (+0.88%)

AZN AstraZeneca
$59.46 /

-0.37 (-0.62%)

AGEN Agenus
$2.82 /

-0.035 (-1.23%)

AGEN Agenus
$2.82 /

-0.035 (-1.23%)

12/16/21 H.C. Wainwright
Agenus initiated with a Buy at H.C. Wainwright
12/06/21 B. Riley
B. Riley bullish on Novavax, Agenus amid Omicron spread
11/09/21 Evercore ISI
Evercore starts Agenus spinout MiNK Therapeutics with an Outperform
10/25/21 B. Riley
Agenus price target lowered to $11 from $12 at B. Riley
AZN AstraZeneca
$59.46 /

-0.37 (-0.62%)

12/30/21 SVB Leerink
SVB Leerink confident Adbry poses minimal competitive risk to Dupixent
12/16/21 Morgan Stanley
AstraZeneca price target raised to 10,200 GBp from 10,000 GBp at Morgan Stanley
12/16/21 Stifel
Adagio story 'even more complicated' after preprints on ADG20, says Stifel
12/12/21 Piper Sandler
Schrodinger MALT1 preclinical data supports IND filing in 1H22, says Piper
BAYRY Bayer
$14.82 /

+0.13 (+0.88%)

11/15/21 AlphaValue/Baader
Bayer upgraded to Buy from Add at AlphaValue/Baader
11/10/21 JPMorgan
Bayer price target raised to EUR 75 from EUR 67 at JPMorgan
11/10/21 Morgan Stanley
Bayer price target raised to EUR 74 from EUR 71 at Morgan Stanley
11/10/21 Credit Suisse
Bayer price target raised to EUR 57 from EUR 55 at Credit Suisse
BMY Bristol-Myers
$64.73 /

-0.175 (-0.27%)

01/10/22 Piper Sandler
Piper says Century Therapeutics' alliance with Bristol 'transformational'
01/03/22 Piper Sandler
Legend Biotech named a top pick for 2022 at Piper Sandler
12/21/21 Oppenheimer
Oppenheimer starts Cytokinetics at Outperform, sees 'blockbuster' potential
12/21/21 Piper Sandler
Legend Biotech initiated with an Overweight at Piper Sandler
CRDF Cardiff Oncology
$4.54 /

-1.585 (-25.88%)

12/07/21 Baird
Cardiff Oncology initiated with an Outperform at Baird
11/18/21 Piper Sandler
Cardiff investment by Pfizer 'some nice validation,' says Piper Sandler
09/09/21 Maxim
Cardiff Oncology price target raised to $25 from $20 at Maxim
09/09/21 Piper Sandler
Cardiff colorectal cancer data 'very consistent,' says Piper Sandler
DSNKY Daiichi Sankyo
$22.44 /

-0.5385 (-2.34%)

10/27/21 SVB Leerink
Seagen price target raised to $200 from $190 at SVB Leerink
03/15/21 Citi
Citi opens 'positive catalyst watch' on Daiichi Sankyo
03/08/21 Goldman Sachs
Daiichi Sankyo upgraded to Buy from Neutral at Goldman Sachs
DCPH Deciphera
$8.50 /

+0.225 (+2.72%)

12/01/21 H.C. Wainwright
Deciphera price target lowered to $15 from $25 at H.C. Wainwright
11/30/21 Piper Sandler
Deciphera price target lowered to $11 from $14 at Piper Sandler
11/08/21 Barclays
Deciphera downgraded to Equal Weight at Barclays after GIST trial miss
11/08/21 Canaccord
Deciphera downgraded to Hold at Canaccord
DNA Ginkgo Bioworks
$5.04 /

-0.25 (-4.73%)

01/06/22 BTIG
BTIG starts Ginkgo Bioworks at Buy with $12 price target
01/06/22 BTIG
Ginkgo Bioworks initiated with a Buy at BTIG
11/29/21 Jefferies
Ginkgo Bioworks initiated with a Buy at Jefferies
10/20/21 Raymond James
Raymond James expects more equity-based payments for Ginkgo as milestones met
ESALY Eisai
$52.17 /

-0.39 (-0.74%)

01/13/22 Citi
Eisai downgraded to Neutral from Buy at Citi
10/08/21 Jefferies
Biogen price target lowered to $400 from $500 at Jefferies
09/30/21 RBC Capital
Prothena price target raised to $82 from $59 at RBC Capital
06/25/21 Morgan Stanley
Eisai downgraded to Equal Weight from Overweight at Morgan Stanley
EXAS Exact Sciences
$76.09 /

-1.24 (-1.60%)

11/03/21 BTIG
Exact Sciences price target lowered to $120 from $145 at BTIG
11/03/21 Craig-Hallum
Exact Sciences price target lowered to $133 from $144 at Craig-Hallum
11/03/21 Raymond James
Exact Sciences downgraded to Outperform from Strong Buy at Raymond James
11/03/21 Wells Fargo
Exact Sciences price target lowered to $95 from $120 at Wells Fargo
EXEL Exelixis
$17.09 /

-0.28 (-1.61%)

11/18/21 Piper Sandler
Exelixis transferred with Overweight at Piper Sandler
11/03/21 H.C. Wainwright
Exelixis price target lowered to $52 from $65 at H.C. Wainwright
10/06/21 Jefferies
Exelixis initiated with a Buy at Jefferies
08/06/21 H.C. Wainwright
Exelixis price target raised to $64 from $35 at H.C. Wainwright
GH Guardant Health
$71.99 /

-0.48 (-0.66%)

10/14/21 Cowen
Guardant Health coverage transferred at Cowen
08/09/21 Canaccord
Guardant Health price target lowered to $180 from $195 at Canaccord
06/21/21 Wells Fargo
Guardant Health price target raised to $160 from $145 at Wells Fargo
06/15/21
Fly Intel: Top five analyst initiations
HCM Hutchmed
$29.71 /

-0.76 (-2.49%)

09/22/21
Fly Intel: Top five analyst downgrades
09/22/21 Goldman Sachs
Hutchmed downgraded to Neutral from Buy at Goldman Sachs
08/03/21 Jefferies
Hutchmed initiated with a Buy at Jefferies
07/13/21 Cantor Fitzgerald
Hutchmed price target raised to $45 from $40 at Cantor Fitzgerald
IMMVF Immunovia
$7.40 /

+ (+0.00%)

12/22/21 Kempen
Immunovia downgraded to Neutral from Buy at Kempen
INCY Incyte
$74.81 /

-0.19 (-0.25%)

01/18/22 RBC Capital
Incyte upgraded to Outperform at RBC Capital on improving 2022 setup
01/18/22 RBC Capital
Incyte upgraded to Outperform from Sector Perform at RBC Capital
01/03/22 Guggenheim
Incyte price target lowered to $104 from $118 at Guggenheim
12/31/21 Benchmark
Incyte, Nektar, Compass Therapeutics named best biotech picks at Benchmark
IPSEY Ipsen
$24.15 /

+0.4145 (+1.75%)

01/11/22 Bryan Garnier
Ipsen upgraded to Buy from Neutral at Bryan Garnier
01/06/22 Societe Generale
Ipsen upgraded to Buy from Hold at Societe Generale
01/04/22 JPMorgan
Ipsen downgraded to Neutral from Overweight at JPMorgan
11/24/21 Berenberg
Ipsen initiated with a Hold at Berenberg
LLY Eli Lilly
$245.08 /

-2.075 (-0.84%)

01/14/22 BofA
Biogen price target lowered to $245 from $275 at BofA
01/12/22 Wells Fargo
CMS proposed coverage with evidence 'a clear negative,' says Wells Fargo
01/05/22 Mizuho
Eli Lilly price target raised to $302 from $272 at Mizuho
01/04/22 Wells Fargo
Eli Lilly price target raised to $280 from $270 at Wells Fargo
MRK Merck
$81.30 /

-0.25 (-0.31%)

12/23/21 Mizuho
Mizuho sees market for both Merck's molnupiravir, Pfizer's Paxlovid
12/17/21 Goldman Sachs
Goldman starts Merck at Conviction Buy with market undervaluing assets
12/17/21 Goldman Sachs
Merck initiated with a Conviction Buy at Goldman Sachs
12/16/21 Daiwa
Merck initiated with a Neutral at Daiwa
MRTX Mirati Therapeutics
$120.93 /

+4.85 (+4.18%)

11/18/21 BMO Capital
Amgen initiated with a Market Perform at BMO Capital
11/18/21 BMO Capital
Mirati Therapeutics initiated with an Outperform at BMO Capital
09/22/21 Stifel
Mirati Therapeutics initiated with a Buy at Stifel
09/22/21 Citi
Mirati Therapeutics price target raised to $244 from $232 at Citi
NTRA Natera
$61.27 /

+0.14 (+0.23%)

01/12/22 BTIG
Natera price target lowered to $150, named one of top 2022 picks at BTIG
01/05/22 Piper Sandler
Natera assumed with an Overweight at Piper Sandler
01/04/22 Canaccord
Natera weakness a buying opportunity, says Canaccord
11/05/21 Baird
Natera price target raised to $152 from $145 at Baird
NVCR Novocure
$64.11 /

-0.37 (-0.57%)

07:49 Today Truist
Novocure upgraded to Buy on more favorable risk-reward at Truist
06:15 Today Truist
Novocure upgraded to Buy from Hold at Truist
01/11/22 Wells Fargo
Novocure price target lowered to $70 from $105 at Wells Fargo
01/10/22 Piper Sandler
Novocure price target lowered to $125 from $130 at Piper Sandler
NVS Novartis
$88.85 /

-0.7 (-0.78%)

01/12/22 Alliance Global Partners
OpGen price target lowered to $3 from $4.35 at Alliance Global Partners
01/10/22 Citi
Novartis resumed with a Buy at Citi
01/06/22 Piper Sandler
Piper want to own Alnylam shares ahead of expected vutrisiran approval
12/15/21 Berenberg
Novartis price target lowered to CHF 85 from CHF 88 at Berenberg
ORIC Oric Pharmaceuticals
$11.72 /

-0.13 (-1.10%)

10/08/21 Baird
Oric Pharmaceuticals price target lowered to $26 from $47 at Baird
10/08/21 Citi
Oric Pharmaceuticals price target lowered to $22 from $33 at Citi
10/08/21 H.C. Wainwright
Oric Pharmaceuticals price target lowered to $30 from $53 at H.C. Wainwright
10/07/21 Oppenheimer
Oppenheimer remains bullish on Oric Pharmaceuticals, says selloff 'overdone'
PBLA Panbela Therapeutics
$1.68 /

-0.06 (-3.45%)

06/28/21 Roth Capital
Panbela Therapeutics initiated with a Buy at Roth Capital
03/10/21 Maxim
Panbela Therapeutics initiated with a Buy at Maxim
PFE Pfizer
$53.54 /

-0.58 (-1.07%)

01/14/22 BMO Capital
Pfizer price target raised to $76 from $60 at BMO Capital
01/11/22 BofA
Pfizer added to US 1 List; Goldman Sachs removed at BofA
01/10/22 Wedbush
Beam Therapeutics price target raised to $159 from $148 at Wedbush
01/05/22 BofA
Pfizer upgraded to Buy from Neutral at BofA
SGEN Seagen
$132.55 /

+2.2 (+1.69%)

11/08/21 Wolfe Research
Seagen initiated with a Peer Perform at Wolfe Research
10/28/21 Piper Sandler
Seagen price target raised to $165 from $160 at Piper Sandler
10/28/21 Piper Sandler
Seagen price target raised to $165 from $160 at Piper Sandler
TPTX Turning Point Therapeutics
$36.57 /

+0.44 (+1.22%)

01/03/22 Guggenheim
Turning Point Therapeutics price target lowered to $107 from $118 at Guggenheim
12/22/21 Roth Capital
Turning Point FDA feedback appears positive, says Roth Capital
12/06/21 Cowen
Turning Point Therapeutics initiated with an Outperform at Cowen
11/15/21 Roth Capital
Turning Point fundamentals strong heading into 2022, says Roth Capital
VCYT Veracyte
$27.23 /

-0.54 (-1.94%)

01/06/22 Stephens
Veracyte initiated with Overweight, named best idea at Stephens
11/18/21 Goldman Sachs
Veracyte reinstated with a Buy at Goldman Sachs
11/10/21 Raymond James
Veracyte price target raised to $62 from $50 at Raymond James
06/28/21 Raymond James
Veracyte price target raised to $50 from $45 at Raymond James
ZYME Zymeworks
$13.44 /

+0.055 (+0.41%)

12/10/21 Raymond James
Zymeworks downgraded to Outperform from Strong Buy at Raymond James
12/10/21 SVB Leerink
Zymeworks upgraded to Outperform from Market Perform at SVB Leerink
12/09/21 Raymond James
Zymeworks downgraded to Outperform from Strong Buy at Raymond James
11/17/21 Guggenheim
Zymeworks assumed with a Neutral at Guggenheim
ZYME Zymeworks
$13.44 /

+0.055 (+0.41%)

VCYT Veracyte
$27.23 /

-0.54 (-1.94%)

TPTX Turning Point Therapeutics
$36.57 /

+0.44 (+1.22%)

SGEN Seagen
$132.55 /

+2.2 (+1.69%)

PFE Pfizer
$53.54 /

-0.58 (-1.07%)

PBLA Panbela Therapeutics
$1.68 /

-0.06 (-3.45%)

ORIC Oric Pharmaceuticals
$11.72 /

-0.13 (-1.10%)

NVS Novartis
$88.85 /

-0.7 (-0.78%)

NVCR Novocure
$64.11 /

-0.37 (-0.57%)

NTRA Natera
$61.27 /

+0.14 (+0.23%)

MRTX Mirati Therapeutics
$120.93 /

+4.85 (+4.18%)

MRK Merck
$81.30 /

-0.25 (-0.31%)

LLY Eli Lilly
$245.08 /

-2.075 (-0.84%)

INCY Incyte
$74.81 /

-0.19 (-0.25%)

GH Guardant Health
$71.99 /

-0.48 (-0.66%)

EXEL Exelixis
$17.09 /

-0.28 (-1.61%)

EXAS Exact Sciences
$76.09 /

-1.24 (-1.60%)

DNA Ginkgo Bioworks
$5.04 /

-0.25 (-4.73%)

DCPH Deciphera
$8.50 /

+0.225 (+2.72%)

CRDF Cardiff Oncology
$4.54 /

-1.585 (-25.88%)

BMY Bristol-Myers
$64.73 /

-0.175 (-0.27%)

BAYRY Bayer
$14.82 /

+0.13 (+0.88%)

AZN AstraZeneca
$59.46 /

-0.37 (-0.62%)

AGEN Agenus
$2.82 /

-0.035 (-1.23%)

  • 11
    Nov
  • 22
    Jul
  • 05
    Feb
ZYME Zymeworks
$13.44 /

+0.055 (+0.41%)

PFE Pfizer
$53.54 /

-0.58 (-1.07%)

NVS Novartis
$88.85 /

-0.7 (-0.78%)

NTRA Natera
$61.27 /

+0.14 (+0.23%)

MRK Merck
$81.30 /

-0.25 (-0.31%)

LLY Eli Lilly
$245.08 /

-2.075 (-0.84%)

GH Guardant Health
$71.99 /

-0.48 (-0.66%)

EXAS Exact Sciences
$76.09 /

-1.24 (-1.60%)

ESALY Eisai
$52.17 /

-0.39 (-0.74%)

DNA Ginkgo Bioworks
$5.04 /

-0.25 (-4.73%)

BMY Bristol-Myers
$64.73 /

-0.175 (-0.27%)

BAYRY Bayer
$14.82 /

+0.13 (+0.88%)

AZN AstraZeneca
$59.46 /

-0.37 (-0.62%)

ZYME Zymeworks
$13.44 /

+0.055 (+0.41%)

VCYT Veracyte
$27.23 /

-0.54 (-1.94%)

SGEN Seagen
$132.55 /

+2.2 (+1.69%)

PFE Pfizer
$53.54 /

-0.58 (-1.07%)

NVS Novartis
$88.85 /

-0.7 (-0.78%)

MRTX Mirati Therapeutics
$120.93 /

+4.85 (+4.18%)

MRK Merck
$81.30 /

-0.25 (-0.31%)

LLY Eli Lilly
$245.08 /

-2.075 (-0.84%)

IPSEY Ipsen
$24.15 /

+0.4145 (+1.75%)

INCY Incyte
$74.81 /

-0.19 (-0.25%)

GH Guardant Health
$71.99 /

-0.48 (-0.66%)

EXEL Exelixis
$17.09 /

-0.28 (-1.61%)

EXAS Exact Sciences
$76.09 /

-1.24 (-1.60%)

DNA Ginkgo Bioworks
$5.04 /

-0.25 (-4.73%)

DCPH Deciphera
$8.50 /

+0.225 (+2.72%)

CRDF Cardiff Oncology
$4.54 /

-1.585 (-25.88%)

BMY Bristol-Myers
$64.73 /

-0.175 (-0.27%)

BAYRY Bayer
$14.82 /

+0.13 (+0.88%)

AZN AstraZeneca
$59.46 /

-0.37 (-0.62%)

AGEN Agenus
$2.82 /

-0.035 (-1.23%)

PFE Pfizer
$53.54 /

-0.58 (-1.07%)

NVS Novartis
$88.85 /

-0.7 (-0.78%)

MRK Merck
$81.30 /

-0.25 (-0.31%)

LLY Eli Lilly
$245.08 /

-2.075 (-0.84%)

INCY Incyte
$74.81 /

-0.19 (-0.25%)

DNA Ginkgo Bioworks
$5.04 /

-0.25 (-4.73%)

BMY Bristol-Myers
$64.73 /

-0.175 (-0.27%)

AZN AstraZeneca
$59.46 /

-0.37 (-0.62%)

AGEN Agenus
$2.82 /

-0.035 (-1.23%)

Over a week ago
Earnings
Exelixis sees preliminary Q4 net product revenue $300M » 19:13
01/09/22
01/09
19:13
01/09/22
19:13
EXEL

Exelixis

$18.76 /

+0.475 (+2.60%)

Total revenue consensus…

Total revenue consensus $348.72M. Sees preliminary FY21 net product revenue of $1.08B, with total revenue consensus at $1.33B, and preliminary FY22 net product revenue between $1.33B-$1.43B, with total revenue consensus $1.58B.

ShowHide Related Items >><<
EXEL Exelixis
$18.76 /

+0.475 (+2.60%)

EXEL Exelixis
$18.76 /

+0.475 (+2.60%)

11/18/21 Piper Sandler
Exelixis transferred with Overweight at Piper Sandler
11/03/21 H.C. Wainwright
Exelixis price target lowered to $52 from $65 at H.C. Wainwright
10/06/21 Jefferies
Exelixis initiated with a Buy at Jefferies
08/06/21 H.C. Wainwright
Exelixis price target raised to $64 from $35 at H.C. Wainwright
EXEL Exelixis
$18.76 /

+0.475 (+2.60%)

EXEL Exelixis
$18.76 /

+0.475 (+2.60%)

Hot Stocks
Exelixis to pay Iconic $55M for rights to use TF antibody incorporated in XB002 » 08:24
01/06/22
01/06
08:24
01/06/22
08:24
EXEL

Exelixis

$18.02 /

-0.74 (-3.94%)

, ZYME

Zymeworks

$15.12 /

-1.075 (-6.64%)

Exelixis (EXEL) and…

Exelixis (EXEL) and Iconic Therapeutics announced that the companies have amended the terms of their May 2019 exclusive option and license agreement for XB002, a next-generation tissue factor or TF targeting antibody-drug conjugate, ADC. Under the amended agreement announced today, Exelixis has acquired broad rights to use the anti-TF antibody incorporated into XB002, for any application, including conjugated to other payloads, as well as rights within oncology to a number of other anti-TF antibodies developed by Iconic, including for use in ADCs and multi-specific biologics. In exchange, Exelixis will make a one-time payment of $55M to Iconic and will not owe any further payments to the company. Exelixis will continue to be responsible for milestone payments and royalties owed to Adimab and royalties owed to Zymeworks (ZYME) pursuant to prior agreements between Iconic and those companies. "We are excited by the early data from the XB002 clinical program and its potential for patients. Tissue factor is a validated target for cancer therapy and may have utility in treating a broad number of cancer types," said Michael Morrissey, Ph.D., President and Chief Executive Officer, Exelixis. "Amending our agreement with Iconic provides Exelixis with an opportunity to build the foundation of a promising franchise in this area and will facilitate the discovery and development of additional TF-targeted biologics potentially addressing a wide range of oncology indications that complement and expand on those targeted by XB002. This could include development of new antibody-drug conjugates with alternative toxin payloads, multi-specific antibodies, and other biologics. We look forward to sharing initial data from the ongoing XB002 phase 1 clinical trial this year." Under the terms of the original May 2019 agreement, Iconic granted Exelixis rights to XB002 and limited rights to the specific anti-TF antibody as incorporated into XB002. The original agreement stipulated that Iconic would be eligible for future development, regulatory and commercialization milestone payments, as well as royalties on potential sales.

ShowHide Related Items >><<
ZYME Zymeworks
$15.12 /

-1.075 (-6.64%)

EXEL Exelixis
$18.02 /

-0.74 (-3.94%)

EXEL Exelixis
$18.02 /

-0.74 (-3.94%)

11/18/21 Piper Sandler
Exelixis transferred with Overweight at Piper Sandler
11/03/21 H.C. Wainwright
Exelixis price target lowered to $52 from $65 at H.C. Wainwright
10/06/21 Jefferies
Exelixis initiated with a Buy at Jefferies
08/06/21 H.C. Wainwright
Exelixis price target raised to $64 from $35 at H.C. Wainwright
ZYME Zymeworks
$15.12 /

-1.075 (-6.64%)

12/10/21 Raymond James
Zymeworks downgraded to Outperform from Strong Buy at Raymond James
12/10/21 SVB Leerink
Zymeworks upgraded to Outperform from Market Perform at SVB Leerink
12/09/21 Raymond James
Zymeworks downgraded to Outperform from Strong Buy at Raymond James
11/17/21 Guggenheim
Zymeworks assumed with a Neutral at Guggenheim
ZYME Zymeworks
$15.12 /

-1.075 (-6.64%)

EXEL Exelixis
$18.02 /

-0.74 (-3.94%)

ZYME Zymeworks
$15.12 /

-1.075 (-6.64%)

ZYME Zymeworks
$15.12 /

-1.075 (-6.64%)

EXEL Exelixis
$18.02 /

-0.74 (-3.94%)

Hot Stocks
Exelixis completes enrollment in CONTACT-03 trial » 08:17
01/05/22
01/05
08:17
01/05/22
08:17
EXEL

Exelixis

$18.76 /

-0.41 (-2.14%)

Exelixis announced that…

Exelixis announced that enrollment is complete for CONTACT-03, the global, phase 3 pivotal trial evaluating the efficacy and safety of cabozantinib in combination with atezolizumab versus cabozantinib alone in patients with locally advanced or metastatic clear cell or non-clear cell renal cell carcinoma who progressed during or following treatment with an immune checkpoint inhibitor as the immediate preceding line of therapy.

ShowHide Related Items >><<
EXEL Exelixis
$18.76 /

-0.41 (-2.14%)

EXEL Exelixis
$18.76 /

-0.41 (-2.14%)

11/18/21 Piper Sandler
Exelixis transferred with Overweight at Piper Sandler
11/03/21 H.C. Wainwright
Exelixis price target lowered to $52 from $65 at H.C. Wainwright
10/06/21 Jefferies
Exelixis initiated with a Buy at Jefferies
08/06/21 H.C. Wainwright
Exelixis price target raised to $64 from $35 at H.C. Wainwright
EXEL Exelixis
$18.76 /

-0.41 (-2.14%)

EXEL Exelixis
$18.76 /

-0.41 (-2.14%)

Initiation
AbCellera initiated with a Buy at Benchmark » 06:13
12/21/21
12/21
06:13
12/21/21
06:13
ABCL

AbCellera

$14.61 /

-0.36 (-2.40%)

Benchmark analyst Robert…

Benchmark analyst Robert Wasserman initiated coverage of AbCellera (ABCL) with a Buy rating and $27 price target. AbCellera's monoclonal antibody discovery technology has produced one of the leading COVID-19 therapeutics to date with partner Eli Lilly (LLY), but the company has a wealth of additional partnership programs, technology platforms and potential "shots on goal" to ensure their next success and future growth, Wasserman tells investors in a research note.

ShowHide Related Items >><<
ABCL AbCellera
$14.61 /

-0.36 (-2.40%)

ABCL AbCellera
$14.61 /

-0.36 (-2.40%)

11/18/21 Piper Sandler
AbCellera initiated with an Overweight at Piper Sandler
11/05/21 Stifel
Stifel sees 'zero change' to Adagio, AbCellera theses due to Pfizer data
10/01/21 Stifel
AbCellera, Adagio reactions to Merck data look 'overdone,' says Stifel
06/11/21 BMO Capital
AbCellera coverage transferred at BMO Capital
ABCL AbCellera
$14.61 /

-0.36 (-2.40%)

ABCL AbCellera
$14.61 /

-0.36 (-2.40%)

ABCL AbCellera
$14.61 /

-0.36 (-2.40%)

Over a month ago
Hot Stocks
Exelixis initiates dose-escalation stage of STELLAR-002 trial » 08:07
12/15/21
12/15
08:07
12/15/21
08:07
EXEL

Exelixis

$16.99 /

-0.025 (-0.15%)

Exelixis announced…

Exelixis announced initiation of the dose-escalation stage of STELLAR-002, a phase 1b trial evaluating XL092 in combination with immuno-oncology therapies in advanced solid tumors. The objective of the study is to evaluate the safety, tolerability and efficacy of XL092, Exelixis' novel next-generation tyrosine kinase inhibitor, or TKI, in combination with: nivolumab; nivolumab and ipilimumab and nivolumab and bempegaldesleukin.

ShowHide Related Items >><<
EXEL Exelixis
$16.99 /

-0.025 (-0.15%)

EXEL Exelixis
$16.99 /

-0.025 (-0.15%)

11/18/21 Piper Sandler
Exelixis transferred with Overweight at Piper Sandler
11/03/21 H.C. Wainwright
Exelixis price target lowered to $52 from $65 at H.C. Wainwright
10/06/21 Jefferies
Exelixis initiated with a Buy at Jefferies
08/06/21 H.C. Wainwright
Exelixis price target raised to $64 from $35 at H.C. Wainwright
EXEL Exelixis
$16.99 /

-0.025 (-0.15%)

EXEL Exelixis
$16.99 /

-0.025 (-0.15%)

On The Fly
Fly Intel: After-Hours Movers » 18:25
12/13/21
12/13
18:25
12/13/21
18:25
REPX

Riley Exploration

$19.00 /

+1 (+5.56%)

, BYND

Beyond Meat

$63.42 /

-1.03 (-1.60%)

, XAIR

Beyond Air

$8.49 /

-0.03 (-0.35%)

, AA

Alcoa

$47.78 /

-1.04 (-2.13%)

, ELY

Callaway Golf

$27.59 /

-0.475 (-1.69%)

, PL

Planet Labs

$8.90 /

-0.565 (-5.97%)

, PTPI

Petros Pharmaceuticals

$3.96 /

+1.28 (+47.76%)

, BLZE

Backblaze

$21.32 /

-0.31 (-1.43%)

, PHX

PHX Minerals

$2.60 /

-0.045 (-1.70%)

, PRPL

Purple Innovation

$9.79 /

-0.21 (-2.10%)

Check out this evening's…

ShowHide Related Items >><<
XAIR Beyond Air
$8.49 /

-0.03 (-0.35%)

REPX Riley Exploration
$19.00 /

+1 (+5.56%)

PTPI Petros Pharmaceuticals
$3.96 /

+1.28 (+47.76%)

PRPL Purple Innovation
$9.79 /

-0.21 (-2.10%)

PL Planet Labs
$8.90 /

-0.565 (-5.97%)

PHX PHX Minerals
$2.60 /

-0.045 (-1.70%)

ELY Callaway Golf
$27.59 /

-0.475 (-1.69%)

BYND Beyond Meat
$63.42 /

-1.03 (-1.60%)

AA Alcoa
$47.78 /

-1.04 (-2.13%)

REPX Riley Exploration
$19.00 /

+1 (+5.56%)

10/07/21 Truist
Riley Exploration price target raised to $54 from $51 at Truist
07/06/21 Truist
Riley Exploration price target raised to $51 from $45 at Truist
06/01/21 Truist
Riley Exploration initiated with a Buy at Truist
06/01/21 Truist
Riley Exploration initiated with a Buy at Truist
BYND Beyond Meat
$63.42 /

-1.03 (-1.60%)

12/13/21 Piper Sandler
Beyond Meat upgraded to Neutral at Piper on pending McDonald's McPlant launch
12/13/21 Piper Sandler
Beyond Meat upgraded to Neutral from Underweight at Piper Sandler
12/03/21 Piper Sandler
Beyond Meat price target lowered to $61 from $72 at Piper Sandler
11/30/21
Fly Intel: Top five analyst initiations
XAIR Beyond Air
$8.49 /

-0.03 (-0.35%)

11/15/21 Roth Capital
Beyond Air price target raised to $15 from $11 at Roth Capital
11/12/21 Oppenheimer
Beyond Air price target raised to $13 from $9 at Oppenheimer
11/12/21 Truist
Beyond Air price target raised to $16 from $12 at Truist
04/28/21
Fly Intel: Top five analyst initiations
AA Alcoa
$47.78 /

-1.04 (-2.13%)

11/16/21 Wolfe Research
Alcoa initiated with an Outperform at Wolfe Research
11/02/21
Fly Intel: Top five analyst upgrades
11/02/21 Jefferies
Alcoa upgraded to Buy from Hold at Jefferies
11/02/21 Jefferies
Alcoa upgraded to Buy from Hold at Jefferies
ELY Callaway Golf
$27.59 /

-0.475 (-1.69%)

11/16/21
Fly Intel: Top five analyst initiations
11/16/21 BofA
Callaway Golf initiated with a Buy at BofA
11/16/21 BofA
Callaway Golf initiated with a Buy at BofA
11/11/21 Compass Point
Callaway Golf price target raised to $38 from $33 at Compass Point
PL Planet Labs
$8.90 /

-0.565 (-5.97%)

09/27/21 Craig-Hallum
dMY Technology Group IV initiated with a Buy, $15 target at Craig-Hallum
PTPI Petros Pharmaceuticals
$3.96 /

+1.28 (+47.76%)

BLZE Backblaze
$21.32 /

-0.31 (-1.43%)

12/06/21 Raymond James
Backblaze initiated with an Outperform at Raymond James
12/06/21 Lake Street
Backblaze initiated with a Buy at Lake Street
12/06/21 B. Riley
B. Riley starts Backblaze at Buy with $29 price target
12/06/21 William Blair
Backblaze initiated with an Outperform at William Blair
PHX PHX Minerals
$2.60 /

-0.045 (-1.70%)

05/14/21 Seaport Global
PHX Minerals initiated with a Buy at Seaport Global
05/03/21
Fly Intel: Top five analyst initiations
05/03/21 Northland
PHX Minerals initiated with an Outperform at Northland
PRPL Purple Innovation
$9.79 /

-0.21 (-2.10%)

11/10/21
Fly Intel: Top five analyst downgrades
11/10/21 Wedbush
Purple Innovation price target lowered to $20 from $37 at Wedbush
11/10/21 B. Riley
Purple Innovation downgraded after second straight miss at B. Riley
11/10/21 Roth Capital
Purple Innovation price target lowered to $18 from $34 at Roth Capital
XAIR Beyond Air
$8.49 /

-0.03 (-0.35%)

REPX Riley Exploration
$19.00 /

+1 (+5.56%)

PRPL Purple Innovation
$9.79 /

-0.21 (-2.10%)

PL Planet Labs
$8.90 /

-0.565 (-5.97%)

PHX PHX Minerals
$2.60 /

-0.045 (-1.70%)

ELY Callaway Golf
$27.59 /

-0.475 (-1.69%)

BYND Beyond Meat
$63.42 /

-1.03 (-1.60%)

BLZE Backblaze
$21.32 /

-0.31 (-1.43%)

AA Alcoa
$47.78 /

-1.04 (-2.13%)

  • 11
    Nov
  • 16
    Sep
  • 30
    Jun
  • 19
    May
  • 16
    Apr
BYND Beyond Meat
$63.42 /

-1.03 (-1.60%)

AA Alcoa
$47.78 /

-1.04 (-2.13%)

XAIR Beyond Air
$8.49 /

-0.03 (-0.35%)

REPX Riley Exploration
$19.00 /

+1 (+5.56%)

PTPI Petros Pharmaceuticals
$3.96 /

+1.28 (+47.76%)

PRPL Purple Innovation
$9.79 /

-0.21 (-2.10%)

ELY Callaway Golf
$27.59 /

-0.475 (-1.69%)

BYND Beyond Meat
$63.42 /

-1.03 (-1.60%)

BLZE Backblaze
$21.32 /

-0.31 (-1.43%)

AA Alcoa
$47.78 /

-1.04 (-2.13%)

XAIR Beyond Air
$8.49 /

-0.03 (-0.35%)

PTPI Petros Pharmaceuticals
$3.96 /

+1.28 (+47.76%)

PL Planet Labs
$8.90 /

-0.565 (-5.97%)

PHX PHX Minerals
$2.60 /

-0.045 (-1.70%)

ELY Callaway Golf
$27.59 /

-0.475 (-1.69%)

BYND Beyond Meat
$63.42 /

-1.03 (-1.60%)

AA Alcoa
$47.78 /

-1.04 (-2.13%)

Hot Stocks
Beyond Air CEO buys $341K in common stock » 18:23
12/13/21
12/13
18:23
12/13/21
18:23
XAIR

Beyond Air

$8.49 /

-0.03 (-0.35%)

In a regulatory filing,…

In a regulatory filing, Beyond Air disclosed that its CEO Steven Lisi bought 40K shares of common stock for $341K on December 10th, boosting his stake by about 4%.

ShowHide Related Items >><<
XAIR Beyond Air
$8.49 /

-0.03 (-0.35%)

XAIR Beyond Air
$8.49 /

-0.03 (-0.35%)

11/15/21 Roth Capital
Beyond Air price target raised to $15 from $11 at Roth Capital
11/12/21 Oppenheimer
Beyond Air price target raised to $13 from $9 at Oppenheimer
11/12/21 Truist
Beyond Air price target raised to $16 from $12 at Truist
04/28/21
Fly Intel: Top five analyst initiations
XAIR Beyond Air
$8.49 /

-0.03 (-0.35%)

XAIR Beyond Air
$8.49 /

-0.03 (-0.35%)

XAIR Beyond Air
$8.49 /

-0.03 (-0.35%)

Options
Largest borrow rate increases among liquid names » 08:45
12/13/21
12/13
08:45
12/13/21
08:45
IONQ

IonQ

$18.57 /

-0.04 (-0.21%)

, ARVL

Arrival Group

$7.82 /

-0.055 (-0.70%)

, ATNF

180 Life Sciences

$4.08 /

+0.08 (+2.00%)

, TGLS

Tecnoglass

$18.73 /

-2.85 (-13.21%)

, GOGL

Golden Ocean

$8.38 /

+0.01 (+0.12%)

, XAIR

Beyond Air

$8.51 /

+0.055 (+0.65%)

, UCO

Universal Compression

$80.88 /

+3.01 (+3.87%)

, STKL

SunOpta

$6.47 /

-0.15 (-2.27%)

, ARKK

ARK Innovation ETF

$96.18 /

-1.54 (-1.58%)

Latest data shows the…

Latest data shows the largest indicative borrow rate increases among liquid option names include: IONQ (IONQ) 10.60% +2.01, Arrival (ARVL) 2.59% +1.17, 180 Life Sciences (ATNF) 9.42% +0.46, Tecnoglass (TGLS) 2.48% +0.28, Golden Ocean (GOGL) 1.56% +0.23, Beyond Air (XAIR) 3.39% +0.22, ProShares UltraShort DJ-UBS Natural Gas (KOLD) 4.75% +0.20, ProShares Ultra DJ UBS Crude Oil (UCO) 2.24% +0.19, SunOpta (STKL) 0.44% +0.17, and ARK Innovation ETF (ARKK) 5.44% +0.17.

ShowHide Related Items >><<
XAIR Beyond Air
$8.51 /

+0.055 (+0.65%)

UCO Universal Compression
$80.88 /

+3.01 (+3.87%)

TGLS Tecnoglass
$18.73 /

-2.85 (-13.21%)

STKL SunOpta
$6.47 /

-0.15 (-2.27%)

IONQ IonQ
$18.57 /

-0.04 (-0.21%)

GOGL Golden Ocean
$8.38 /

+0.01 (+0.12%)

ATNF 180 Life Sciences
$4.08 /

+0.08 (+2.00%)

ARVL Arrival Group
$7.82 /

-0.055 (-0.70%)

IONQ IonQ
$18.57 /

-0.04 (-0.21%)

11/21/21 Goldman Sachs
IonQ initiated with a Neutral at Goldman Sachs
11/16/21 Benchmark
IonQ price target raised to $28 from $18 at Benchmark
11/16/21 Craig-Hallum
IonQ price target raised to $26 from $20 at Craig-Hallum
07/08/21 Benchmark
dMY Technology Group, Inc. III initiated with a Buy at Benchmark
ARVL Arrival Group
$7.82 /

-0.055 (-0.70%)

12/02/21 UBS
Arrival Group initiated with a Neutral at UBS
10/06/21
Fly Intel: Top five analyst initiations
10/06/21 Berenberg
Berenberg starts 'differentiated' Arrival with Buy, $17 price target
10/06/21 Berenberg
Arrival initiated with a Buy at Berenberg
ATNF 180 Life Sciences
$4.08 /

+0.08 (+2.00%)

09/15/21 Maxim
180 Life Sciences initiated with a Buy at Maxim
09/15/21 Maxim
180 Life Sciences initiated with a Buy at Maxim
TGLS Tecnoglass
$18.73 /

-2.85 (-13.21%)

12/10/21 Sidoti
Tecnoglass upgraded to Buy from Neutral at Sidoti
12/09/21 Baird
Tecnoglass 'has real operations and real customers,' says Baird
12/09/21 B. Riley
Tecnoglass fundamentals suggest buying on selloff, says B. Riley
11/09/21 B. Riley
Tecnoglass upgraded to Buy on market share gains at B. Riley
GOGL Golden Ocean
$8.38 /

+0.01 (+0.12%)

09/13/21 H.C. Wainwright
Golden Ocean initiated with a Neutral at H.C. Wainwright
05/04/21 BTIG
Golden Ocean price target raised to $12 from $8 at BTIG
02/08/21 BTIG
Golden Ocean price target raised to $7 from $6 at BTIG
XAIR Beyond Air
$8.51 /

+0.055 (+0.65%)

11/15/21 Roth Capital
Beyond Air price target raised to $15 from $11 at Roth Capital
11/12/21 Oppenheimer
Beyond Air price target raised to $13 from $9 at Oppenheimer
11/12/21 Truist
Beyond Air price target raised to $16 from $12 at Truist
04/28/21
Fly Intel: Top five analyst initiations
UCO Universal Compression
$80.88 /

+3.01 (+3.87%)

STKL SunOpta
$6.47 /

-0.15 (-2.27%)

11/11/21 Canaccord
SunOpta price target lowered to $15 from $20 at Canaccord
09/10/21 Cowen
Cowen starts SunOpta at Outperform with $15 price target
09/10/21 Cowen
SunOpta initiated with an Outperform at Cowen
08/11/21 Lake Street
Lake Street remains bullish on SunOpta following quarterly results
ARKK ARK Innovation ETF
$96.18 /

-1.54 (-1.58%)

XAIR Beyond Air
$8.51 /

+0.055 (+0.65%)

TGLS Tecnoglass
$18.73 /

-2.85 (-13.21%)

STKL SunOpta
$6.47 /

-0.15 (-2.27%)

GOGL Golden Ocean
$8.38 /

+0.01 (+0.12%)

ARVL Arrival Group
$7.82 /

-0.055 (-0.70%)

  • 19
    Nov
GOGL Golden Ocean
$8.38 /

+0.01 (+0.12%)

XAIR Beyond Air
$8.51 /

+0.055 (+0.65%)

TGLS Tecnoglass
$18.73 /

-2.85 (-13.21%)

IONQ IonQ
$18.57 /

-0.04 (-0.21%)

GOGL Golden Ocean
$8.38 /

+0.01 (+0.12%)

ARVL Arrival Group
$7.82 /

-0.055 (-0.70%)

UCO Universal Compression
$80.88 /

+3.01 (+3.87%)

TGLS Tecnoglass
$18.73 /

-2.85 (-13.21%)

IONQ IonQ
$18.57 /

-0.04 (-0.21%)

GOGL Golden Ocean
$8.38 /

+0.01 (+0.12%)

ATNF 180 Life Sciences
$4.08 /

+0.08 (+2.00%)

ARVL Arrival Group
$7.82 /

-0.055 (-0.70%)

ARKK ARK Innovation ETF
$96.18 /

-1.54 (-1.58%)

ARKK ARK Innovation ETF
$96.18 /

-1.54 (-1.58%)

On The Fly
Wall Street in Fives - Must Read Lists for Thursday » 16:27
12/09/21
12/09
16:27
12/09/21
16:27
CVS

CVS Health

$97.30 /

+4.21 (+4.52%)

, HRL

Hormel Foods

$44.83 /

+2.04 (+4.77%)

, GME

GameStop

$155.64 /

-17.93 (-10.33%)

, RENT

Rent The Runway

$11.02 /

-0.44 (-3.84%)

, CIEN

Ciena

$71.90 /

+9.83 (+15.84%)

, LUV

Southwest

$43.61 /

-1.65 (-3.65%)

, AMD

AMD

$138.00 /

-7.24 (-4.98%)

, EVGO

EVgo

$12.85 /

+0.68 (+5.59%)

, FUBO

FuboTV

$18.86 /

-0.91 (-4.60%)

, NVEI

Nuvei

$60.81 /

+2.96 (+5.12%)

, SBUX

Starbucks

$115.34 /

-0.9 (-0.77%)

, AMZN

Amazon.com

$3,483.27 /

-39.93 (-1.13%)

, CG

Carlyle Group

$54.01 /

-0.61 (-1.12%)

, APO

Apollo Global

$70.52 /

-0.59 (-0.83%)

, DD

DuPont

$78.60 /

+0.325 (+0.42%)

, FB

Facebook; also tag MVRS

$330.04 /

-0.49 (-0.15%)

, MVRS

Meta

/

+

, AAPL

Apple

$174.56 /

-0.43 (-0.25%)

, HRTX

Heron Therapeutics

$9.29 /

+0.945 (+11.32%)

, AUPH

Aurinia Pharmaceuticals

$20.96 /

+0.06 (+0.29%)

, XAIR

Beyond Air

$8.46 /

-2.095 (-19.86%)

, MOGO

Mogo

$3.95 /

-0.745 (-15.88%)

, KGC

Kinross Gold

$5.27 /

-0.615 (-10.45%)

, GTBAF

Great Bear Resources

$23.00 /

+4.9 (+27.07%)

, HOV

Hovnanian

$122.72 /

+14.72 (+13.63%)

, RH

RH

$609.77 /

+32.0499 (+5.55%)

, RNG

RingCentral

$185.93 /

-28.75 (-13.39%)

, IRBT

iRobot

$71.22 /

-4.47 (-5.91%)

, IPAR

Inter Parfums

$95.12 /

-0.15 (-0.16%)

Get caught up quickly on…

ShowHide Related Items >><<
XAIR Beyond Air
$8.46 /

-2.095 (-19.86%)

SBUX Starbucks
$115.34 /

-0.9 (-0.77%)

RNG RingCentral
$185.93 /

-28.75 (-13.39%)

RH RH
$609.77 /

+32.0499 (+5.55%)

NVEI Nuvei
$60.81 /

+2.96 (+5.12%)

MVRS Meta
/

+

MOGO Mogo
$3.95 /

-0.745 (-15.88%)

LUV Southwest
$43.61 /

-1.65 (-3.65%)

KGC Kinross Gold
$5.27 /

-0.615 (-10.45%)

IRBT iRobot
$71.22 /

-4.47 (-5.91%)

IPAR Inter Parfums
$95.12 /

-0.15 (-0.16%)

HRTX Heron Therapeutics
$9.29 /

+0.945 (+11.32%)

HRL Hormel Foods
$44.83 /

+2.04 (+4.77%)

HOV Hovnanian
$122.72 /

+14.72 (+13.63%)

GME GameStop
$155.64 /

-17.93 (-10.33%)

FUBO FuboTV
$18.86 /

-0.91 (-4.60%)

FB Facebook; also tag MVRS
$330.04 /

-0.49 (-0.15%)

EVGO EVgo
$12.85 /

+0.68 (+5.59%)

DD DuPont
$78.60 /

+0.325 (+0.42%)

CVS CVS Health
$97.30 /

+4.21 (+4.52%)

CIEN Ciena
$71.90 /

+9.83 (+15.84%)

CG Carlyle Group
$54.01 /

-0.61 (-1.12%)

AUPH Aurinia Pharmaceuticals
$20.96 /

+0.06 (+0.29%)

APO Apollo Global
$70.52 /

-0.59 (-0.83%)

AMZN Amazon.com
$3,483.27 /

-39.93 (-1.13%)

AMD AMD
$138.00 /

-7.24 (-4.98%)

AAPL Apple
$174.56 /

-0.43 (-0.25%)

CVS CVS Health
$97.30 /

+4.21 (+4.52%)

12/10/21 RBC Capital
CVS Health price target raised to $119 from $107 at RBC Capital
12/10/21 Credit Suisse
CVS Health price target raised to $120 from $107 at Credit Suisse
12/10/21 Mizuho
CVS Health price target raised to $110 from $105 at Mizuho
12/01/21
Fly Intel: Top five analyst initiations
HRL Hormel Foods
$44.83 /

+2.04 (+4.77%)

12/10/21 Piper Sandler
Hormel Foods price target raised to $49 from $45 at Piper Sandler
10/08/21
Fly Intel: Top five analyst upgrades
10/08/21 JPMorgan
Hormel Foods upgraded to Neutral from Underweight at JPMorgan
09/03/21 Barclays
Hormel Foods price target lowered to $46 from $48 at Barclays
GME GameStop
$155.64 /

-17.93 (-10.33%)

12/09/21 Baird
GameStop transformation details 'remain a mystery,' says Baird
12/09/21 Wedbush
GameStop price target lowered to $45 from $50 at Wedbush
09/27/21 Ascendiant
Ascendiant keeps Sell rating on GameStop, cuts price target to $24
07/12/21 Ascendiant
GameStop price target raised to $25 from $10 at Ascendiant
RENT Rent The Runway
$11.02 /

-0.44 (-3.84%)

12/09/21 Morgan Stanley
Rent The Runway path to profitability still underestimated, says Morgan Stanley
12/09/21 Piper Sandler
Rent The Runway price target raised to $23 from $22 at Piper Sandler
11/22/21
Fly Intel: Top five analyst initiations
11/22/21 Morgan Stanley
Morgan Stanley starts 'underestimated' Rent The Runway with an Overweight
CIEN Ciena
$71.90 /

+9.83 (+15.84%)

12/10/21 B. Riley
Ciena price target raised to $63 from $51 at B. Riley
12/10/21 Citi
Ciena price target raised to $85 from $70 at Citi
12/10/21 Raymond James
Ciena price target raised to $75 from $64 at Raymond James
12/10/21 Barclays
Ciena price target raised to $84 from $66 at Barclays
LUV Southwest
$43.61 /

-1.65 (-3.65%)

12/10/21 Goldman Sachs
Southwest downgraded to Sell from Neutral at Goldman Sachs
12/09/21 UBS
UBS downgrades Southwest to Neutral on continuing cost pressures
12/09/21 UBS
Southwest downgraded to Neutral from Buy at UBS
12/09/21 Morgan Stanley
Southwest price target lowered to $65 from $71 at Morgan Stanley
AMD AMD
$138.00 /

-7.24 (-4.98%)

12/09/21 Erste Group
AMD downgraded to Hold from Buy at Erste Group
11/15/21 Citi
October notebook shipments 'good news' for Intel and AMD, says Citi
11/09/21 Wedbush
AMD price target raised to $165 from $140 at Wedbush
11/09/21 Susquehanna
AMD price target raised to $175 from $145 at Susquehanna
EVGO EVgo
$12.85 /

+0.68 (+5.59%)

12/09/21
Fly Intel: Top five analyst initiations
12/09/21 JPMorgan
EVgo initiated with an Overweight at JPMorgan
11/23/21 Capital One
EVgo initiated with an Equalweight at Capital One
11/15/21 BofA
EVgo downgraded earlier to Underperform from Neutral at BofA
FUBO FuboTV
$18.86 /

-0.91 (-4.60%)

12/09/21 JPMorgan
FuboTV initiated with an Overweight at JPMorgan
11/15/21 Barrington
FuboTV downgraded to Market Perform from Outperform at Barrington
11/15/21 Barrington
FuboTV downgraded to Market Perform from Outperform at Barrington
NVEI Nuvei
$60.81 /

+2.96 (+5.12%)

12/09/21 Keefe Bruyette
Keefe Bruyette doesn't see 'smoking gun' in Nuvei short report
12/09/21
Fly Intel: Top five analyst upgrades
12/09/21 RBC Capital
RBC Capital says points raised by short report on Nuvei 'not material' to thesis
12/09/21 National Bank
National Bank says Nuvei short report does not change investment thesis
SBUX Starbucks
$115.34 /

-0.9 (-0.77%)

12/07/21
Fly Intel: Top five analyst upgrades
12/07/21 MKM Partners
Starbucks upgraded to Buy from Neutral at MKM Partners
11/04/21
Fly Intel: Top five analyst downgrades
11/04/21 Argus
Starbucks downgraded to Hold from Buy at Argus
AMZN Amazon.com
$3,483.27 /

-39.93 (-1.13%)

12/06/21 Lake Street
Backblaze initiated with a Buy at Lake Street
12/06/21 B. Riley
B. Riley starts Backblaze at Buy with $29 price target
12/06/21 Wedbush
Wedbush initiates Rivian Automotive with an Outperform, $130 price target
CG Carlyle Group
$54.01 /

-0.61 (-1.12%)

11/02/21 Citi
Carlyle Group price target raised to $73 from $66 at Citi
10/29/21 Deutsche Bank
Carlyle Group price target raised to $70 from $63 at Deutsche Bank
10/29/21 BMO Capital
T. Rowe Price price target raised to $253 from $234 at BMO Capital
10/29/21 Oppenheimer
Carlyle Group price target raised to $77 from $69 at Oppenheimer
APO Apollo Global
$70.52 /

-0.59 (-0.83%)

11/09/21 Truist
Athene Holding price target raised to $88 from $68 at Truist
11/09/21 Argus
Apollo Global price target raised to $90 from $76 at Argus
11/05/21
Fly Intel: Top five analyst upgrades
11/05/21 Deutsche Bank
Deutsche Bank upgrades Apollo to Buy says Athene deal 'stands out'
DD DuPont
$78.60 /

+0.325 (+0.42%)

11/03/21
Fly Intel: Top five analyst upgrades
11/03/21 BMO Capital
DuPont price target raised to $101 from $96 at BMO Capital
11/03/21 Deutsche Bank
DuPont price target raised to $95 from $92 at Deutsche Bank
11/03/21 Mizuho
DuPont price target raised to $96 from $94 at Mizuho
FB Facebook; also tag MVRS
$330.04 /

-0.49 (-0.15%)

12/06/21 HSBC
HSBC upgrades Meta to Hold after 19% selloff from peak
12/06/21 HSBC
Meta upgraded to Hold from Reduce at HSBC
12/02/21 UBS
Meta assumed with a Buy at UBS
11/19/21 JMP Securities
DoubleVerify may see $200M opportunity from Facebook news, says JMP Securities
MVRS Meta
/

+

AAPL Apple
$174.56 /

-0.43 (-0.25%)

12/09/21 Barclays
Barclays says new Google Search app pop-up could signal risk to Apple
12/09/21 B. Riley
B. Riley says 'excellent time' to buy Globalstar on iPhone inclusion evidence
12/09/21 Morgan Stanley
Apple stay on App Store injunction an 'upside surprise,' says Morgan Stanley
12/09/21 Wedbush
iPhone demand outstripping supply, Glasses set for 2022 debut, says Wedbush
HRTX Heron Therapeutics
$9.29 /

+0.945 (+11.32%)

07/26/21 JPMorgan
JPMorgan upgrades Pacira amid recovery in elective procedures
05/10/21 Cantor Fitzgerald
Cantor Fitzgerald remains bullish on Heron amid HTX-011 labeling discussions
01/21/21 SVB Leerink
Pacira downgraded to Market Perform from Outperform at SVB Leerink
AUPH Aurinia Pharmaceuticals
$20.96 /

+0.06 (+0.29%)

12/10/21 Oppenheimer
Aurinia Pharmaceuticals upgraded to Outperform from Perform at Oppenheimer
11/04/21 H.C. Wainwright
Aurinia Pharmaceuticals price target raised to $40 from $35 at H.C. Wainwright
10/28/21 Oppenheimer
Aurinia Pharmaceuticals downgraded to Perform on valuation at Oppenheimer
10/28/21 Oppenheimer
Aurinia Pharmaceuticals downgraded to Perform from Outperform at Oppenheimer
XAIR Beyond Air
$8.46 /

-2.095 (-19.86%)

11/15/21 Roth Capital
Beyond Air price target raised to $15 from $11 at Roth Capital
11/12/21 Oppenheimer
Beyond Air price target raised to $13 from $9 at Oppenheimer
11/12/21 Truist
Beyond Air price target raised to $16 from $12 at Truist
04/28/21
Fly Intel: Top five analyst initiations
MOGO Mogo
$3.95 /

-0.745 (-15.88%)

12/09/21 BTIG
Mogo capital raise may be used for deal with Coinsquare, says BTIG
09/24/21 H.C. Wainwright
Mogo price target lowered to $12 from $16 at H.C. Wainwright
08/12/21 Raymond James
Mogo price target lowered to C$13.50 from C$15 at Raymond James
07/08/21 BTIG
Mogo's Coinsquare stake more interesting after Tetra Trust investment, says BTIG
KGC Kinross Gold
$5.27 /

-0.615 (-10.45%)

10/12/21 Credit Suisse
Credit Suisse sees 're-rating potential' for gold valuation multiples
07/30/21 Canaccord
Kinross Gold price target lowered to C$12.50 from C$13.50 at Canaccord
07/30/21 National Bank
Kinross Gold upgraded to Outperform from Sector Perform at National Bank
07/16/21 National Bank
Kinross Gold price target raised to C$11 from C$10 at National Bank
GTBAF Great Bear Resources
$23.00 /

+4.9 (+27.07%)

12/06/21 Canaccord
Great Bear Resources price target raised to C$27 from C$23.50 at Canaccord
10/04/21 Stifel
Great Bear Resources price target raised to C$27 from C$22 at Stifel
05/06/21 Noble Capital
Great Bear Resources initiated with an Outperform at Noble Capital
04/06/21 BMO Capital
Great Bear Resources initiated with an Outperform at BMO Capital
HOV Hovnanian
$122.72 /

+14.72 (+13.63%)

RH RH
$609.77 /

+32.0499 (+5.55%)

12/09/21 Wedbush
RH price target raised to $650 from $600 at Wedbush
12/09/21 Citi
RH price target lowered to $766 from $790 at Citi
12/06/21 Wedbush
RH price target lowered to $600 from $760 at Wedbush
11/29/21 BofA
Arhaus initiated with a Buy at BofA
RNG RingCentral
$185.93 /

-28.75 (-13.39%)

12/09/21 BTIG
RingCentral price target lowered to $350 from $400 at BTIG
12/09/21 Mizuho
RingCentral price target lowered to $300 from $400 at Mizuho
12/09/21 Deutsche Bank
RingCentral price target lowered to $300 from $400 at Deutsche Bank
11/10/21 Needham
RingCentral price target raised to $400 from $360 at Needham
IRBT iRobot
$71.22 /

-4.47 (-5.91%)

09/09/21 Raymond James
iRobot revealed most significant new software in years, says Raymond James
07/29/21 JPMorgan
iRobot downgraded to Neutral from Overweight at JPMorgan
02/12/21 Northland
iRobot price target raised to $140 from $120 at Northland
02/12/21 Citi
iRobot price target raised to $140 from $95 at Citi
IPAR Inter Parfums
$95.12 /

-0.15 (-0.16%)

11/29/21 BWS Financial
Inter Parfums price target raised to $125 from $100 at BWS Financial
11/18/21 Citi
Inter Parfums price target raised to $104 from $100 at Citi
11/10/21 DA Davidson
Inter Parfums price target raised to $113 from $100 at DA Davidson
11/10/21 Citi
Inter Parfums price target raised to $100 from $84 at Citi
XAIR Beyond Air
$8.46 /

-2.095 (-19.86%)

SBUX Starbucks
$115.34 /

-0.9 (-0.77%)

RNG RingCentral
$185.93 /

-28.75 (-13.39%)

RH RH
$609.77 /

+32.0499 (+5.55%)

RENT Rent The Runway
$11.02 /

-0.44 (-3.84%)

NVEI Nuvei
$60.81 /

+2.96 (+5.12%)

MOGO Mogo
$3.95 /

-0.745 (-15.88%)

LUV Southwest
$43.61 /

-1.65 (-3.65%)

KGC Kinross Gold
$5.27 /

-0.615 (-10.45%)

IRBT iRobot
$71.22 /

-4.47 (-5.91%)

IPAR Inter Parfums
$95.12 /

-0.15 (-0.16%)

HRTX Heron Therapeutics
$9.29 /

+0.945 (+11.32%)

HRL Hormel Foods
$44.83 /

+2.04 (+4.77%)

HOV Hovnanian
$122.72 /

+14.72 (+13.63%)

GME GameStop
$155.64 /

-17.93 (-10.33%)

FUBO FuboTV
$18.86 /

-0.91 (-4.60%)

FB Facebook; also tag MVRS
$330.04 /

-0.49 (-0.15%)

EVGO EVgo
$12.85 /

+0.68 (+5.59%)

DD DuPont
$78.60 /

+0.325 (+0.42%)

CVS CVS Health
$97.30 /

+4.21 (+4.52%)

CIEN Ciena
$71.90 /

+9.83 (+15.84%)

CG Carlyle Group
$54.01 /

-0.61 (-1.12%)

AUPH Aurinia Pharmaceuticals
$20.96 /

+0.06 (+0.29%)

APO Apollo Global
$70.52 /

-0.59 (-0.83%)

AMZN Amazon.com
$3,483.27 /

-39.93 (-1.13%)

AMD AMD
$138.00 /

-7.24 (-4.98%)

AAPL Apple
$174.56 /

-0.43 (-0.25%)

  • 10
    Nov
  • 27
    Oct
  • 06
    Oct
  • 19
    May
  • 12
    Mar
  • 30
    Dec
SBUX Starbucks
$115.34 /

-0.9 (-0.77%)

RH RH
$609.77 /

+32.0499 (+5.55%)

NVEI Nuvei
$60.81 /

+2.96 (+5.12%)

MVRS Meta
/

+

LUV Southwest
$43.61 /

-1.65 (-3.65%)

HOV Hovnanian
$122.72 /

+14.72 (+13.63%)

GME GameStop
$155.64 /

-17.93 (-10.33%)

FUBO FuboTV
$18.86 /

-0.91 (-4.60%)

FB Facebook; also tag MVRS
$330.04 /

-0.49 (-0.15%)

EVGO EVgo
$12.85 /

+0.68 (+5.59%)

DD DuPont
$78.60 /

+0.325 (+0.42%)

CVS CVS Health
$97.30 /

+4.21 (+4.52%)

CG Carlyle Group
$54.01 /

-0.61 (-1.12%)

AUPH Aurinia Pharmaceuticals
$20.96 /

+0.06 (+0.29%)

APO Apollo Global
$70.52 /

-0.59 (-0.83%)

AMZN Amazon.com
$3,483.27 /

-39.93 (-1.13%)

AMD AMD
$138.00 /

-7.24 (-4.98%)

AAPL Apple
$174.56 /

-0.43 (-0.25%)

XAIR Beyond Air
$8.46 /

-2.095 (-19.86%)

SBUX Starbucks
$115.34 /

-0.9 (-0.77%)

RNG RingCentral
$185.93 /

-28.75 (-13.39%)

RH RH
$609.77 /

+32.0499 (+5.55%)

NVEI Nuvei
$60.81 /

+2.96 (+5.12%)

MOGO Mogo
$3.95 /

-0.745 (-15.88%)

LUV Southwest
$43.61 /

-1.65 (-3.65%)

IRBT iRobot
$71.22 /

-4.47 (-5.91%)

IPAR Inter Parfums
$95.12 /

-0.15 (-0.16%)

HRL Hormel Foods
$44.83 /

+2.04 (+4.77%)

GME GameStop
$155.64 /

-17.93 (-10.33%)

FUBO FuboTV
$18.86 /

-0.91 (-4.60%)

FB Facebook; also tag MVRS
$330.04 /

-0.49 (-0.15%)

EVGO EVgo
$12.85 /

+0.68 (+5.59%)

DD DuPont
$78.60 /

+0.325 (+0.42%)

CVS CVS Health
$97.30 /

+4.21 (+4.52%)

CG Carlyle Group
$54.01 /

-0.61 (-1.12%)

AUPH Aurinia Pharmaceuticals
$20.96 /

+0.06 (+0.29%)

APO Apollo Global
$70.52 /

-0.59 (-0.83%)

AMZN Amazon.com
$3,483.27 /

-39.93 (-1.13%)

AMD AMD
$138.00 /

-7.24 (-4.98%)

SBUX Starbucks
$115.34 /

-0.9 (-0.77%)

RH RH
$609.77 /

+32.0499 (+5.55%)

RENT Rent The Runway
$11.02 /

-0.44 (-3.84%)

NVEI Nuvei
$60.81 /

+2.96 (+5.12%)

MOGO Mogo
$3.95 /

-0.745 (-15.88%)

LUV Southwest
$43.61 /

-1.65 (-3.65%)

KGC Kinross Gold
$5.27 /

-0.615 (-10.45%)

IRBT iRobot
$71.22 /

-4.47 (-5.91%)

GME GameStop
$155.64 /

-17.93 (-10.33%)

FUBO FuboTV
$18.86 /

-0.91 (-4.60%)

FB Facebook; also tag MVRS
$330.04 /

-0.49 (-0.15%)

EVGO EVgo
$12.85 /

+0.68 (+5.59%)

DD DuPont
$78.60 /

+0.325 (+0.42%)

CVS CVS Health
$97.30 /

+4.21 (+4.52%)

CIEN Ciena
$71.90 /

+9.83 (+15.84%)

AUPH Aurinia Pharmaceuticals
$20.96 /

+0.06 (+0.29%)

APO Apollo Global
$70.52 /

-0.59 (-0.83%)

AMZN Amazon.com
$3,483.27 /

-39.93 (-1.13%)

AMD AMD
$138.00 /

-7.24 (-4.98%)

AAPL Apple
$174.56 /

-0.43 (-0.25%)

AAPL Apple
$174.56 /

-0.43 (-0.25%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.